Comparison between First- and Second-Generation Cryoballoon for Paroxysmal Atrial Fibrillation Ablation

Cardiology Research and Practice

4 May May 2016 9 years ago
  • Conti S, Moltrasio M, Fassini G, Tundo F, Riva S, Dello Russo A, Casella M, Majocchi B, Marino V, De Iuliis P, Catto V, Pala S, Tondo C
QR Code

Cryoballoon (CB) ablation has emerged as a novel treatment for pulmonary vein isolation (PVI) for patients with paroxysmal atrial fibrillation (PAF). The second-generation Arctic Front Advance (ADV) was redesigned with technical modifications aiming at procedural and outcome improvements.

The Authors aimed to compare the efficacy of the two different technologies over a long-term follow-up. The ADV catheter compared to the first-generation balloon allows obtaining a significantly higher success rate after a single PVI procedure during the long-term follow-up. Fluoroscopy and procedural times were significantly shortened using the ADV catheter.

Reference
Conti S, Moltrasio M, Fassini G, Tundo F, Riva S, Dello Russo A, Casella M, Majocchi B, Marino V, De Iuliis P, Catto V, Pala S, Tondo C. Comparison between First- and Second-Generation Cryoballoon for Paroxysmal Atrial Fibrillation Ablation. Cardiol Res Pract 2016;2016:5106127. Go to full text